Cours MiMedx Group Inc Nasdaq
Actions
US6024961012
Recherche biotechnologique et médicale
CA 2024 * | 357 M 326 M | CA 2025 * | 403 M 368 M | Capitalisation | 925 M 845 M |
---|---|---|---|---|---|
Résultat net 2024 * | 43 M 39,27 M | Résultat net 2025 * | 56 M 51,14 M | VE / CA 2024 * | 2,59 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,29 x |
PER 2024 * |
20,4
x | PER 2025 * |
16,1
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,76% |
Dernier transcript sur MiMedx Group Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 19/06/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
-20,60% | 128 M | |
-7,82% | 67,46 M | |
+14,87% | 61,68 M | |
+6,64% | 60,58 M | |
+0,60% | 51,45 M |